Trials / Completed
CompletedNCT00140569
Randomized Study for Patients With Follicular Lymphoma Needing Treatment
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 400 (planned)
- Sponsor
- Lymphoma Study Association · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
2 parallel studies. * For young patients (18-60 years): randomization between CHVP + interferon for 18 months and 4 CHOP followed by autotransplant after TBI * For elderly patients (\>60 years): randomization between CHVP + interferon for 18 months and fludarabine 5 days every months for 6 months
Detailed description
2 parallel studies. * For young patients (18-60 years): randomization between CHVP + interferon for 18 months and 4 CHOP followed by autotransplant after TBI * For elderly patients (\>60 years): randomization between CHVP + interferon for 18 months and fludarabine 5 days every months for 6 months
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | CHVP + interferon | |
| DRUG | fludarabine | |
| PROCEDURE | CHOP + TBI and autotransplant |
Timeline
- Start date
- 1994-01-01
- Completion
- 2004-01-01
- First posted
- 2005-09-01
- Last updated
- 2005-09-01
Locations
8 sites across 2 countries: Belgium, France
Source: ClinicalTrials.gov record NCT00140569. Inclusion in this directory is not an endorsement.